KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Inventory (2018 - 2025)

Twist Bioscience (TWST) has disclosed Inventory for 8 consecutive years, with $32.9 million as the latest value for Q4 2025.

  • Quarterly Inventory rose 39.99% to $32.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $32.9 million through Dec 2025, up 39.99% year-over-year, with the annual reading at $28.3 million for FY2025, 17.57% up from the prior year.
  • Inventory for Q4 2025 was $32.9 million at Twist Bioscience, up from $28.3 million in the prior quarter.
  • The five-year high for Inventory was $44.6 million in Q4 2022, with the low at $15.8 million in Q1 2021.
  • Average Inventory over 5 years is $31.7 million, with a median of $31.3 million recorded in 2021.
  • The sharpest move saw Inventory surged 200.09% in 2021, then tumbled 31.33% in 2025.
  • Over 5 years, Inventory stood at $40.2 million in 2021, then rose by 10.83% to $44.6 million in 2022, then plummeted by 30.8% to $30.9 million in 2023, then dropped by 23.8% to $23.5 million in 2024, then surged by 39.99% to $32.9 million in 2025.
  • According to Business Quant data, Inventory over the past three periods came in at $32.9 million, $28.3 million, and $25.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.